StockDriftsStockDriftsCG Invites (083790) has 205 disclosed insider purchases and 1 disclosed disposals on record, filed by 10 distinct insiders. Together those filings cover ₩10.0B ($6.9M) in reported transaction value. The earliest filing StockDrifts holds for CG Invites is dated 2024-02-29; the most recent is 2026-06-29. Across these filings the average return since disclosure is -34.53%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-07-14 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 5.6K | ₩851 | -9.5% | ₩5M ($3K) |
| 2026-07-13 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 6.1K | ₩858 | -10.3% | ₩5M ($4K) |
| 2026-07-10 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 1.2K | ₩899 | -14.3% | ₩1M ($733) |
| 2026-06-29 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 63.5K | ₩1,000 | -23.0% | ₩64M ($44K) |
| 2026-06-29 | BUY | 신규선임 | 김유정 Kim Yu-jeong | Internal director | 67.0K | ₩1,000 | -11.9% | ₩67M ($47K) |
| 2026-06-26 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 50.5K | ₩1,018 | -24.4% | ₩52M ($36K) |
| 2026-06-25 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 65.6K | ₩1,025 | -24.9% | ₩67M ($47K) |
| 2026-06-24 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 96.4K | ₩1,001 | -23.1% | ₩97M ($68K) |
| 2026-06-23 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 118.0K | ₩1,020 | -24.5% | ₩121M ($84K) |
| 2026-06-22 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 37.9K | ₩1,033 | -25.5% | ₩39M ($27K) |
| 2026-06-19 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 60.4K | ₩1,030 | -25.2% | ₩62M ($43K) |
| 2026-06-18 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 78.4K | ₩1,024 | -24.8% | ₩80M ($56K) |
| 2026-06-17 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 67.2K | ₩1,008 | -23.6% | ₩68M ($47K) |
| 2026-06-16 | BUY | Market Buy | 인바이츠투자 Invites Investment | - | 29.0K | ₩970 | -20.6% | ₩28M ($19K) |
| 2026-06-05 | BUY | Market Buy | 신호종 signal bell | vice president | 17.8K | ₩900 | +3.3% | ₩16M ($11K) |
| 2026-06-05 | BUY | Market Buy | 이호영 Hoyoung Lee | CEO | 6.0K | ₩900 | +3.3% | ₩5M ($4K) |
| 2026-06-05 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 39.5K | - | - | - |
| 2026-06-04 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 82.5K | - | - | - |
| 2026-06-02 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 199.5K | - | - | - |
| 2026-06-01 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 71.5K | - | - | - |
| 2026-06-01 | BUY | Market Buy | 이호영 Hoyoung Lee | CEO | 17.4K | ₩899 | +3.5% | ₩16M ($11K) |
| 2026-06-01 | BUY | Market Buy | 신호종 signal bell | vice president | 32.2K | ₩899 | +3.5% | ₩29M ($20K) |
| 2026-05-29 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 15.5K | - | - | - |
| 2026-05-28 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 13.0K | - | - | - |
| 2026-05-26 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 9.8K | - | - | - |
| 2026-05-21 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 27.0K | ₩1,068 | -27.9% | ₩29M ($20K) |
| 2026-05-20 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 23.0K | ₩1,120 | -31.3% | ₩25M ($17K) |
| 2026-05-14 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 38.5K | ₩1,190 | -35.3% | ₩45M ($31K) |
| 2026-05-13 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 71.0K | ₩1,196 | -35.6% | ₩84M ($58K) |
| 2026-05-12 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 32.0K | ₩1,217 | -36.7% | ₩38M ($26K) |
| 2026-05-11 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 31.5K | ₩1,145 | -32.8% | ₩36M ($25K) |
| 2026-05-08 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 3.0K | ₩1,166 | -1.4% | ₩3M ($2K) |
| 2026-05-07 | BUY | Market Buy | 인바이츠바이오코아 Invites Biocore | - | 16.0K | ₩1,170 | -1.7% | ₩19M ($13K) |
| 2026-04-30 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 9.3K | ₩1,258 | -8.6% | ₩12M ($8K) |
| 2026-04-29 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 15.0K | ₩1,271 | -9.5% | ₩19M ($13K) |
| 2026-04-28 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 15.0K | ₩1,270 | -9.4% | ₩19M ($13K) |
| 2026-04-21 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 11.5K | ₩1,330 | -13.5% | ₩15M ($11K) |
| 2026-04-09 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 17.0K | ₩1,272 | -9.6% | ₩22M ($15K) |
| 2026-04-08 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 57.0K | ₩1,309 | -12.2% | ₩75M ($52K) |
| 2026-04-07 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 30.1K | ₩1,324 | -13.1% | ₩40M ($28K) |
| 2026-03-26 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 71.0K | ₩1,585 | -27.4% | ₩112M ($78K) |
| 2026-03-24 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 15.5K | ₩1,500 | -23.3% | ₩23M ($16K) |
| 2026-03-23 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 12.5K | ₩1,515 | -24.1% | ₩19M ($13K) |
| 2026-03-19 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 61.0K | ₩1,519 | -24.3% | ₩93M ($64K) |
| 2026-03-18 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 102.0K | ₩1,530 | -24.8% | ₩156M ($108K) |
| 2026-02-27 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 8.8K | ₩1,452 | -20.8% | ₩13M ($9K) |
| 2026-02-25 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 11.1K | ₩1,303 | -11.7% | ₩14M ($10K) |
| 2026-02-24 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 22.0K | ₩1,301 | -11.6% | ₩29M ($20K) |
| 2026-02-23 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 36.3K | ₩1,241 | -7.3% | ₩45M ($31K) |
| 2026-02-19 | BUY | Market Buy | 인바이츠지노믹스 Invites Genomics | - | 13.5K | ₩1,290 | -10.8% | ₩17M ($12K) |
Showing the 50 most recent of 200 filings.
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.